These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 15681596
1. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy. Kim K, Chie EK, Kim CW, Kim IH, Park CI. Jpn J Clin Oncol; 2005 Jan; 35(1):1-5. PubMed ID: 15681596 [Abstract] [Full Text] [Related]
2. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases]. Pan ZH, Huang HQ, Lin XB, Xia YF, Xia ZJ, Peng YL, Cai QQ, Lin TY, Jiang WQ, Guan ZZ. Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799 [Abstract] [Full Text] [Related]
4. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J. Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611 [Abstract] [Full Text] [Related]
6. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases. Niibe Y, Hayakawa K, Kitano M, Ishiyama H, Nakayama M, Yao K, Okamoto M. Anticancer Res; 2005 Jan; 25(6C):4403-6. PubMed ID: 16334116 [Abstract] [Full Text] [Related]
7. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Huang MJ, Jiang Y, Liu WP, Li ZP, Li M, Zhou L, Xu Y, Yu CH, Li Q, Peng F, Liu JY, Luo F, Lu Y. Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):166-74. PubMed ID: 17919841 [Abstract] [Full Text] [Related]
8. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Isobe K, Uno T, Tamaru J, Kawakami H, Ueno N, Wakita H, Okada J, Itami J, Ito H. Cancer; 2006 Feb 01; 106(3):609-15. PubMed ID: 16369986 [Abstract] [Full Text] [Related]
9. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Yong W, Zheng W, Zhu J, Zhang Y, Wei Y, Wang X, Lin N, Xie Y, Xu B, Li J. Hematol Oncol; 2006 Mar 01; 24(1):28-32. PubMed ID: 16323259 [Abstract] [Full Text] [Related]
10. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF. Zhonghua Zhong Liu Za Zhi; 2006 Jan 01; 28(1):58-61. PubMed ID: 16737624 [Abstract] [Full Text] [Related]
11. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383 [Abstract] [Full Text] [Related]
12. [Clinical features and prognosis of nasal type NK/T cell lymphoma]. Zhang YJ, Hu WH, Liu H, Cheng EC, Ren ZM, Xia YF, Cui NJ. Zhonghua Zhong Liu Za Zhi; 2006 Jan 01; 28(1):50-3. PubMed ID: 16737622 [Abstract] [Full Text] [Related]
13. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type. Shim SJ, Yang WI, Shin E, Koom WS, Kim YB, Cho JH, Suh CO, Kim JH, Kim GE. Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):31-8. PubMed ID: 17049184 [Abstract] [Full Text] [Related]
14. [Case series of localized nasal NK/T-cell lymphoma treated with preceding intensified local radiation therapy before systemic chemotherapy]. Tamai Y, Imataki O, Abe Y, Hagiwara S, Ito I, Asakura H, Harada H, Kamata M, Nishimura T, Kawakami K. Gan To Kagaku Ryoho; 2006 May 01; 33(5):687-90. PubMed ID: 16685174 [Abstract] [Full Text] [Related]
16. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K. J Clin Oncol; 2009 Nov 20; 27(33):5594-600. PubMed ID: 19805668 [Abstract] [Full Text] [Related]
17. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Ko YH, Ahn YC, Park K. Eur J Cancer; 2005 Jul 20; 41(10):1402-8. PubMed ID: 15963893 [Abstract] [Full Text] [Related]
18. [Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases]. Huang Y, Lin TY, Wu QL, Su ZL, Huang HQ, Xia ZJ, Sun XF, Jiang WQ, Guan ZZ. Ai Zheng; 2005 Apr 20; 24(4):470-4. PubMed ID: 15820072 [Abstract] [Full Text] [Related]
19. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma]. Yao B, Li YX, Fang H, Yu ZH, Jin J, Liu XF. Zhonghua Xue Ye Xue Za Zhi; 2006 Apr 20; 27(4):222-5. PubMed ID: 16875550 [Abstract] [Full Text] [Related]
20. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma]. Cui XZ, Wang HQ, Liu XM, Zhang HL, Li W. Zhonghua Xue Ye Xue Za Zhi; 2007 Sep 20; 28(9):609-11. PubMed ID: 18246818 [Abstract] [Full Text] [Related] Page: [Next] [New Search]